A Comissão deve proceder a uma avaliação adequada dos resultados da análise de Bromazolam.

Resumo

Em 16 de março de 2026, a Drug Enforcement Administration publicou uma ordem temporária colocando 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepina (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, Isomers, & salts of Isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that included an invalid